The effects of anandamide and oleamide on cognition depend on diurnal variations
Pavel E Rueda-Orozco1, Corinne J Montes-Rodriguez2, Alejandra E Ruiz-Contreras3
1Departamento de Neurofisiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, UNAM, Mexico.
Abstract:
Cannabinergic receptor 1 (CB1r) is highly expressed in almost the entire brain; hence, its activation affects diverse functions, including cognitive processes such as learning and memory. On the other hand, it has been demonstrated that CB1r expression fluctuates along the light-dark cycle. In this context, the objective of this work was to characterize the cannabinergic influence over cognitive processes and its relationship with the light-dark cycle. To this aim we studied the effects of two endogenous cannabinoids, anandamide (AEA) and oleamide (ODA), on the consolidation of memory and event-related potentials (ERPs) depending on the light-dark cycle. Our results indicate that AEA and ODA impair the consolidation of spatial and emotional memories and reduce the amplitude of several components of the ERP complex, depending on the phase of the light-dark cycle. This study further supports the notion that endocannabinoids participate in the regulation of cognitive processes with strong influence of environmental variables such as the light-dark cycle.
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Circadian Rhythms and Gene Regulation
Drug Abuse and Addiction: Pharmacological Phenomena


